Aurobindo Pharma gets USFDA nod for anti-infection drug

25 May 2011 Evaluate

Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Piperacillin and Tazobactam for injection.

Piperacillin and Tazobactam for injection are the generic equivalent of Wyeth's Zosyn injection indicated for the treatment of moderate to severe systemic and/or local bacterial infections in which betalactamase producing bacteria are suspected.The approved drugs have a market size of approximately $635 million for the twelve months ending September 2010.

crackcrack

Aurobindo Pharma Share Price

1129.45 16.10 (1.45%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.